UPDATE: Wells Fargo Reinstates Merck (MRK) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
Go back to UPDATE: Wells Fargo Reinstates Merck (MRK) at Overweight
December 8, 2021 5:49 AM EST
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today priced an $8.0 billion public offering of five series of senior unsecured notes (collectively, the notes). The notes include:
$1.5 billion of 1.700% notes due 2027 (the 2027 notes)
$1.0 billion of 1.900% notes due 2028 (the sustainability notes)
$2.0 billion of 2.150% notes due 2031 (the 2031 notes)
$2.0 billion of 2.750% notes due 2051 (the 2051 notes)
$1.5 billion of 2.900% notes due 2061 (the 2061 notes)
Merck intends to use the net proceeds from the offering of the 2027... More
December 7, 2021 1:12 PM EST
Merck (NYSE: MRK) to sell $8 billion in bonds for Acceleron Pharma (NASDAQ: XLRN) deal - Bloomberg
...
More
December 7, 2021 6:12 AM EST
Guggenheim analyst Seamus Fernandez downgraded Merck (NYSE: MRK) from Buy to Neutral.
For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.
Shares of Merck closed at $73.42 yesterday.
...
More
